CTRO-1013 An investigational liver-targeted siRNA designed to silence IRS1 as a potential treatment for metabolic liver disease.
Visit productCosigns Received
Be the first Cosign
Put your name behind CTRO-1013.
Add it to your Products I use list and share why you use it.